share_log

Labcorp to Announce Second Quarter Financial Results on August 1, 2024

Labcorp to Announce Second Quarter Financial Results on August 1, 2024

Labcorp將於2024年8月1日公佈第二季度財務業績。
PR Newswire ·  07/01 07:00

BURLINGTON, N.C., July 1, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2024 before the market opens on Thursday, August 1, 2024. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.

全球領先的創新型綜合實驗室服務提供商Labcorp(紐交所:LH)將於2024年8月1日星期四市場開盤前發佈2024年第二季度業績。當天上午9點將舉行電話會議和網絡直播說明財務報告。公司將在Labcorp投資者關係網站上發佈收益新聞稿和財務信息。

The call will be webcast live on the Labcorp Investor Relations website. Participants may also register for the call by clicking on this link, to receive the dial-in numbers and unique PIN to access the call. The webcast and dial-in are listen-only. It is recommended that participants join 10 minutes prior to the start, although participants may register and join at any time during the call.

電話會議將在Labcorp投資者關係網站上進行網絡直播。參與者也可以通過單擊此鏈接註冊參加電話會議,以獲得撥入號碼和獨特的個人識別碼以接入電話會議。網絡直播和撥入電話僅供聽取。建議參與者提前10分鐘加入,雖然參與者可以在電話會議期間隨時註冊並加入。

A replay of the webcast will be available approximately two hours after the conclusion of the live event and will be available until July 18, 2025. To access the webcast recording, visit the Labcorp Investor Relations website.

直播的重播將於現場活動結束後約兩個小時後提供,並可在2025年7月18日之前訪問Labcorp投資者關係網站以訪問直播的錄像。

About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for 84% of the new drugs and therapeutic products approved in 2023 by the FDA, and performed more than 600 million tests for patients around the world. Learn more about us at .

關於Labcorp
Labcorp(紐交所:LH)是全球領先的創新和綜合性的實驗室服務提供商,幫助醫生、醫院、製藥公司、研究人員和患者做出明智的決策。我們通過普遍診斷和藥物開發實驗室能力提供洞察力和推進科學,以改善健康和生活。該公司員工超過67,000人,在約100個國家爲客戶提供服務,爲美國84%的FDA批准的新藥物和治療產品提供支持,併爲全球患者進行了超過6億次測試。了解更多關於我們的資訊,請訪問。

SOURCE Labcorp Holdings Inc

Labcorp Holdings Inc的消息來源

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論